Holen Sie sich die Stockscreener-App
1.50
9.64%
-0.16
Handel nachbörslich:
1.45
-0.05
-3.33%
Schlusskurs vom Vortag:
$1.66
Offen:
$1.63
24-Stunden-Volumen:
2.41M
Relative Volume:
3.08
Marktkapitalisierung:
$73.57M
Einnahmen:
$134.60K
Nettoeinkommen (Verlust:
$-11.81M
KGV:
-6.2267
EPS:
-0.2409
Netto-Cashflow:
$-10.05M
1W Leistung:
+24.48%
1M Leistung:
+17.19%
6M Leistung:
-0.66%
1J Leistung:
-9.64%
1-Tages-Spanne:
$1.49
$1.69
1-Wochen-Bereich:
$1.168
$1.96
52-Wochen-Spanne:
$1.13
$2.55
Medicinova Inc Stock (MNOV) Company Profile
Firmenname
Medicinova Inc
Sektor
Branche
Telefon
858-373-1500
Adresse
4275 EXECUTIVE SQUARE, LA JOLLA, CA
Vergleichen Sie MNOV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MNOV
Medicinova Inc
|
1.50 | 81.42M | 134.60K | -11.81M | -10.05M | -0.2409 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Medicinova Inc Stock (MNOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-10 | Eingeleitet | Maxim Group | Buy |
| 2019-03-25 | Fortgesetzt | B. Riley FBR | Buy |
| 2018-03-28 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-04-18 | Eingeleitet | Credit Suisse | Outperform |
| 2013-01-04 | Bestätigt | Ladenburg Thalmann | Buy |
| 2012-05-24 | Herabstufung | MLV & Co | Buy → Hold |
| 2011-10-18 | Bestätigt | MLV Capital | Buy |
| 2011-06-22 | Eingeleitet | Global Hunter Securities | Buy |
| 2010-05-12 | Eingeleitet | Wedbush | Outperform |
| 2008-11-12 | Bestätigt | Ladenburg Thalmann | Buy |
| 2008-05-15 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
| 2007-07-09 | Eingeleitet | Punk, Ziegel & Co | Buy |
Alle ansehen
Medicinova Inc Aktie (MNOV) Neueste Nachrichten
Applying big data sentiment scoring on MediciNova Inc.July 2025 Setups & Free Accurate Trade Setup Notifications - newser.com
Is MediciNova Inc. stock a contrarian buyEarnings Overview Summary & Fast Exit and Entry Trade Guides - newser.com
Will MediciNova Inc. stock maintain growth storyWeekly Stock Summary & Daily Stock Trend Reports - newser.com
What’s next for MediciNova Inc. stock price2025 Trade Ideas & Weekly Setup with ROI Potential - newser.com
What Fibonacci levels say about MediciNova Inc. rebound2025 Earnings Impact & Weekly Market Pulse Updates - newser.com
Market reaction to MediciNova Inc.’s recent newsJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - newser.com
Key resistance and support levels for MediciNova Inc.Forecast Cut & Free Technical Pattern Based Buy Signals - newser.com
What dividend safety score for MediciNova Inc. stockStop Loss & Momentum Based Trading Signals - newser.com
3 Penny Stocks With Market Caps Over $80M To Consider - simplywall.st
Trend analysis for MediciNova Inc. this weekJuly 2025 Snapshot & Advanced Swing Trade Entry Plans - newser.com
How currency fluctuations impact MediciNova Inc. stockWeekly Earnings Recap & Long-Term Investment Growth Plans - newser.com
Applying Elliott Wave Theory to MediciNova Inc.Trend Reversal & Weekly Setup with High ROI Potential - newser.com
Will MediciNova Inc. stock remain a Wall Street favorite2025 Stock Rankings & Weekly Breakout Stock Alerts - newser.com
Developing predictive dashboards with MediciNova Inc. dataWeekly Trade Review & Weekly Top Gainers Trade List - newser.com
MediciNova Research Sparks New Hope for Atherosclerosis Therapy - StocksToTrade
MediciNova’s Breakthrough Strategy in Atherosclerosis Treatment - timothysykes.com
MediciNova, Inc. (MNOV) Stock Price, News, Quote & History - Yahoo! Finance Canada
MediciNova Stock Rockets 85% After-Hours On Promising Heart Study — Traders Hope For ‘Big Green Candle’ - Stocktwits
Will MediciNova Inc. stock benefit from infrastructure spendingJuly 2025 EndofMonth & Verified Technical Signals - newser.com
MediciNova Advances Atherosclerosis Research with Novel Therapeutic Strategy - StocksToTrade
MediciNova’s New Research Drives Strategic Focus on Cholesterol Metabolism - timothysykes.com
MediciNova compounds demonstrate novel therapeutic approach for Atherosclerosis - Yahoo Finance
MediciNova Stock Surge: Unveiling the Latest Development - timothysykes.com
MediciNova (MNOV) Analyst Ratings: Consistent 'Buy' Rating Maint - GuruFocus
D. Boral Capital Maintains MediciNova (MNOV) Buy Recommendation - Nasdaq
Why Did MediciNova Stock (MNOV) Jump Over 87% In After-Hours Trading? - Benzinga
MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in ... - Enidnews.com
MediciNova, Inc. Publishes Research on MN-002's Potential in Atherosclerosis Treatment in Journal of Atherosclerosis and Thrombosis - Quiver Quantitative
MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication - The Manila Times
MediciNova (NASDAQ: MNOV) publishes tipelukast data: MN-002 enhances cholesterol efflux - Stock Titan
RMN.BE interactive stock chart | Medicinova Inc. R stock - Yahoo! Finance Singapore
Finanzdaten der Medicinova Inc-Aktie (MNOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):